GoodRx (GDRX) operating cash flow was $168M in FY2025 (-9% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$168M
-9%
2024
$184M
+33%
2023
$138M
-6%
2022
$147M
-18%
2021
$179M
+36%
2020
$131M
+58%
2019
$83M
+84%
2018
$45M
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$81M
Q1 2026
$12M
Q4 2025
$33M
Q3 2025
$76M
Q2 2025
$50M
Q1 2025
$9M
Q4 2024
$45M
Q3 2024
$87M
Q2 2024
$10M
Q1 2024
$43M
Q4 2023
$16M
Q3 2023
$60M
Source: GDRX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.